✦ LIBER ✦

Metastatic bladder cancer: Advances in treatment

✍ Scribed by W.M. Stadler; T.M. Kuzel; D. Raghavan; E. Levine; N.J. Vogelzang; B. Roth; F.A. Dorr

Book ID: 117663596
Publisher: Elsevier Science
Year: 1997
Tongue: English
Weight: 395 KB
Volume: 33
Category: Article
ISSN: 0959-8049
DOI: 10.1016/s0959-8049(96)00337-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

874 POSTER Gemcitabine monotherapy in th

874 POSTER Gemcitabine monotherapy in the treatment of locally advanced/metastatic bilharzial-related bladder cancer: a follow up report

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 142 KB

The systemic treatment of advanced and m

The systemic treatment of advanced and metastatic bladder cancer

✍ Syed A Hussain; Nicholas D James 📂 Article 📅 2003 🏛 The Lancet 🌐 English ⚖ 436 KB

Locally advanced and metastatic bladder

Locally advanced and metastatic bladder cancer

✍ Robert Dreicer 📂 Article 📅 2001 🏛 Springer 🌐 English ⚖ 195 KB

154 INVITED Recent advances in metastati

154 INVITED Recent advances in metastatic bladder cancer

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 173 KB

Chemotherapy in Locally Advanced and Met

Chemotherapy in Locally Advanced and Metastatic Bladder Cancer

✍ Markus A. Kuczyk; Reinhold Zimmermann; Axel Merseburger; Ares Anastasiadis; Stef 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 227 KB

Gemcitabine in locally advanced and/or m

Gemcitabine in locally advanced and/or metastatic bladder cancer

✍ Hans von der Maase 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 90 KB

Gemcitabine is a promising new drug in patients with locally advanced and/or metastatic transitional cell carcinoma of the urothelium. The drug has been tested as a single-agent in one phase I study and four phase II studies. Gemcitabine was administered on days 1, 8 and 15 every 28 days with a dose